EA201591023A1 - SOLID FORM OF DERIVATIVE DIHYDROPYRIDOOXAZINE - Google Patents
SOLID FORM OF DERIVATIVE DIHYDROPYRIDOOXAZINEInfo
- Publication number
- EA201591023A1 EA201591023A1 EA201591023A EA201591023A EA201591023A1 EA 201591023 A1 EA201591023 A1 EA 201591023A1 EA 201591023 A EA201591023 A EA 201591023A EA 201591023 A EA201591023 A EA 201591023A EA 201591023 A1 EA201591023 A1 EA 201591023A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- dihydropyridooxazine
- derivative
- solid form
- forms
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Изобретение относится к безводной кристаллической форме (1,1-диоксогексагидро-1лямбда*6*-тиопиран-4-ил)-{(S)-3-[1-(6-метокси-5-метилпиридин-3-ил)-2,3-дигидро-1Н-пиридо[3,4-b][1,4]оксазин-7-илокси]пирролидин-1-ил}метанона; фармацевтическим композициям и комбинациям, содержащим такие формы, а также к способам применения этих форм, включая их фармацевтические композиции и комбинации для лечения заболеваний.The invention relates to the anhydrous crystalline form (1,1-dioxohexahydro-1Lambda * 6 * -thiopyran-4-yl) - {(S) -3- [1- (6-methoxy-5-methylpyridin-3-yl) -2 , 3-dihydro-1H-pyrido [3,4-b] [1,4] oxazin-7-yloxy] pyrrolidin-1-yl} methanone; pharmaceutical compositions and combinations containing such forms, as well as to methods of using these forms, including their pharmaceutical compositions and combinations for the treatment of diseases.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GC201222895 | 2012-11-26 | ||
PCT/IB2013/060412 WO2014102630A1 (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201591023A1 true EA201591023A1 (en) | 2015-09-30 |
EA028031B1 EA028031B1 (en) | 2017-09-29 |
Family
ID=54198861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591023A EA028031B1 (en) | 2012-11-26 | 2013-11-26 | Solid form of dihydro-pyrido-oxazine derivative |
Country Status (8)
Country | Link |
---|---|
JP (1) | JP6310474B2 (en) |
EA (1) | EA028031B1 (en) |
ES (1) | ES2643902T3 (en) |
HR (1) | HRP20171573T1 (en) |
HU (1) | HUE036665T2 (en) |
LT (1) | LT2928896T (en) |
MA (1) | MA38100A1 (en) |
SI (1) | SI2928896T1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2010027002A1 (en) * | 2008-09-05 | 2012-02-02 | 塩野義製薬株式会社 | Fused morpholine derivative having PI3K inhibitory activity |
IN2014CN04174A (en) * | 2011-12-22 | 2015-09-04 | Novartis Ag |
-
2013
- 2013-11-26 EA EA201591023A patent/EA028031B1/en not_active IP Right Cessation
- 2013-11-26 HU HUE13824177A patent/HUE036665T2/en unknown
- 2013-11-26 LT LTEP13824177.3T patent/LT2928896T/en unknown
- 2013-11-26 MA MA38100A patent/MA38100A1/en unknown
- 2013-11-26 ES ES13824177.3T patent/ES2643902T3/en active Active
- 2013-11-26 JP JP2015543559A patent/JP6310474B2/en active Active
- 2013-11-26 SI SI201330781T patent/SI2928896T1/en unknown
-
2017
- 2017-10-17 HR HRP20171573TT patent/HRP20171573T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUE036665T2 (en) | 2018-07-30 |
SI2928896T1 (en) | 2017-10-30 |
MA38100A1 (en) | 2017-12-29 |
EA028031B1 (en) | 2017-09-29 |
HRP20171573T1 (en) | 2017-11-17 |
JP2016502531A (en) | 2016-01-28 |
JP6310474B2 (en) | 2018-04-11 |
LT2928896T (en) | 2017-09-25 |
ES2643902T3 (en) | 2017-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201590879A1 (en) | ARYL-CONDENSED AND HETEROARYL-CONDENSED LACTAMS | |
EA201990240A1 (en) | NEW TRICYCLIC CONNECTIONS AS ANTICATIVE AGENTS | |
EA201492216A1 (en) | Bromodomain inhibitors and their use | |
EA201890333A1 (en) | ANTI-VIRUS COMPOUNDS | |
EA201391532A1 (en) | Condensed Heterocyclic Compounds As Modulators of Ion Channels | |
EA201591166A1 (en) | AUTOTAXIN INHIBITORS | |
EA201590868A1 (en) | ANTI-VIRUS COMPOUNDS | |
EA201492002A1 (en) | ANTI-VIRUS COMPOUNDS | |
EA200901157A1 (en) | CONDENSED RING HETEROCYCLIC KINASE MODULATORS | |
EA201290980A1 (en) | DERIVATIVES OF 1-AMINO-2-CYCLOPROPYLETHYLBURONIC ACID | |
EA201400976A1 (en) | BENZODIOXANES IN COMBINATION WITH OTHER ACTIVE MEANS TO INHIBIT LEUKOTRIEN PRODUCTION | |
EA201790417A3 (en) | Condensed Heterocyclic Compounds As Modulators of Ion Channels | |
EA201500298A1 (en) | ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES | |
EA201200176A1 (en) | OXAZIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | |
EA201590381A1 (en) | REPLACED PYRAZOLES USED AS BLOCATORS OF N-TYPE CALCIUM CHANNELS | |
EA201490888A1 (en) | NEW PURIN DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
EA201490272A1 (en) | NEW 4-PIPERIDINYL COMPOUNDS FOR USE AS TANKIRASE INHIBITORS | |
EA201100138A1 (en) | 4-PHENOXYMETHYL-PIPERIDINES AS MODEL ACTIVITY GPR119 | |
EA201301181A1 (en) | TRIAZOLOPRYRIDINS | |
EA201500182A1 (en) | 4-METHYL-2,3,5,9,9b-PENTAASACYCLOPENT [a] NAFTAIL | |
EA201170356A1 (en) | POLYMORPHIC AND AMORPHOUS FORMS OF LACOSAMIDE AND AMORPHOUS COMPOSITIONS | |
EA201590228A1 (en) | ANTAGONISTS 5-HT3 RECEPTOR | |
EA201100161A1 (en) | QUINUCLIDINE CARBONATE DERIVATIVES AND THEIR MEDICAL COMPOSITIONS | |
EA201200570A1 (en) | COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS | |
EA201290744A1 (en) | IMIDAZO [1,2-B] [1,2,4] TRIAZINS AS C-MET INHIBITORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY KZ |